Effects of Botulinum Toxin Injections in Patients With Hereditary Spastic Paraplegia

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

March 9, 2016

Primary Completion Date

March 15, 2017

Study Completion Date

March 15, 2017

Conditions
Hereditary Spastic Paraplegia
Interventions
OTHER

Botulinum Toxin Injections

Each patient in the treatment group will receive 400 units of botulinum toxin. 100 units will be injected at adductors at each leg and 100 units will be applied in each triceps surae bilaterally.

OTHER

Placebo Injections

Each patient in the placebo group will receive sterile sodium chloride injections at adductors and triceps surae muscles bilaterally.

Trial Locations (1)

13083-888

Univeristy of Campinas Hospital, Campinas

All Listed Sponsors
collaborator

Conselho Nacional de Desenvolvimento Científico e Tecnológico

OTHER_GOV

collaborator

Cristália Produtos Químicos Farmacêuticos Ltda.

INDUSTRY

lead

University of Campinas, Brazil

OTHER

NCT02604186 - Effects of Botulinum Toxin Injections in Patients With Hereditary Spastic Paraplegia | Biotech Hunter | Biotech Hunter